Cryptic Exons as a Source of Increased Diversity of Ewing Tumor-Associated EWS–FLI1 Chimeric Products

This publication has 8 references indexed in Scilit:

• Chromosome translocation based on illegitimate recombination in human tumors
  Proceedings of the National Academy of Sciences, 1998
• Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains
  Oncogene, 1998
• EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
  Journal of Clinical Oncology, 1998
• Progress in the Molecular Biology of Ewing Tumors
  Sarcoma, 1998
• Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data
  British Journal of Cancer, 1994
• The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
  New England Journal of Medicine, 1994
• DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
  Molecular and Cellular Biology, 1994
• Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.
  Proceedings of the National Academy of Sciences, 1993